Matches in SemOpenAlex for { <https://semopenalex.org/work/W2185409974> ?p ?o ?g. }
- W2185409974 abstract "The presence of IL-17-positive cells is observed in a variety of inflammatory associated cancers and IL-17 has been found to be involved in angiogenesis. However, it remains unclear how IL-17 might contribute to tumor angiogenesis. In our study, IL-17 enhanced the formation of vessel-like tubes in HUVECs both directly (when HUVECs were incubated with IL-17) and indirectly (when HUVECs were incubated in conditioned cell media (CCM) from IL-17-treated cancer cells). Our results from experiments using siRNA-mediated knockdowns of STAT3 and GIV suggest that the effects of IL-17 were mediated by activating STAT3/GIV signaling in NSCLC cells and subsequently up-regulating its downstream target VEGF. Consistent with these findings, immunostaining experiments on human NSCLC tissues indicated that IL-17 and GIV expression were significantly and positively associated with increased tumor vascularity. The clinical significance of IL-17 was authenticated by our finding that the combination of intratumoral IL-17 + cells and GIV expression served as a better prognosticator for survival than either marker alone. Therefore, our finding highlights a novel aspect of STAT3/GIV pathway in the IL-17 promotes tumor angiogenesis of NSCLC." @default.
- W2185409974 created "2016-06-24" @default.
- W2185409974 creator A5008765259 @default.
- W2185409974 creator A5023460508 @default.
- W2185409974 creator A5029780470 @default.
- W2185409974 creator A5034906860 @default.
- W2185409974 creator A5050193171 @default.
- W2185409974 creator A5055567713 @default.
- W2185409974 creator A5070264785 @default.
- W2185409974 creator A5081445104 @default.
- W2185409974 creator A5085025467 @default.
- W2185409974 creator A5087378677 @default.
- W2185409974 date "2015-11-03" @default.
- W2185409974 modified "2023-10-18" @default.
- W2185409974 title "Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non-small-cell lung cancer" @default.
- W2185409974 cites W1573363574 @default.
- W2185409974 cites W1821858011 @default.
- W2185409974 cites W1859224551 @default.
- W2185409974 cites W1935309503 @default.
- W2185409974 cites W1948284414 @default.
- W2185409974 cites W1965831940 @default.
- W2185409974 cites W1966542709 @default.
- W2185409974 cites W1966768211 @default.
- W2185409974 cites W1967663251 @default.
- W2185409974 cites W1978254668 @default.
- W2185409974 cites W1980814049 @default.
- W2185409974 cites W1989588757 @default.
- W2185409974 cites W2000000541 @default.
- W2185409974 cites W2000102677 @default.
- W2185409974 cites W2007897471 @default.
- W2185409974 cites W2011445291 @default.
- W2185409974 cites W2014077602 @default.
- W2185409974 cites W2020188870 @default.
- W2185409974 cites W2020233428 @default.
- W2185409974 cites W2033509933 @default.
- W2185409974 cites W2046388159 @default.
- W2185409974 cites W2048113014 @default.
- W2185409974 cites W2048653810 @default.
- W2185409974 cites W2049094526 @default.
- W2185409974 cites W2050643405 @default.
- W2185409974 cites W2053968039 @default.
- W2185409974 cites W2056794357 @default.
- W2185409974 cites W2075854792 @default.
- W2185409974 cites W2085332471 @default.
- W2185409974 cites W2089502469 @default.
- W2185409974 cites W2092289533 @default.
- W2185409974 cites W2099113429 @default.
- W2185409974 cites W2102978104 @default.
- W2185409974 cites W2103366137 @default.
- W2185409974 cites W2108341352 @default.
- W2185409974 cites W2117564254 @default.
- W2185409974 cites W2121487670 @default.
- W2185409974 cites W2123140856 @default.
- W2185409974 cites W2135855165 @default.
- W2185409974 cites W2147784618 @default.
- W2185409974 cites W2149003918 @default.
- W2185409974 cites W2151055438 @default.
- W2185409974 cites W2156201599 @default.
- W2185409974 cites W2160258620 @default.
- W2185409974 cites W2160433176 @default.
- W2185409974 cites W2160476332 @default.
- W2185409974 cites W2162667703 @default.
- W2185409974 cites W2170189698 @default.
- W2185409974 cites W2397734749 @default.
- W2185409974 cites W2783142245 @default.
- W2185409974 cites W2899025319 @default.
- W2185409974 doi "https://doi.org/10.1038/srep16053" @default.
- W2185409974 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4630609" @default.
- W2185409974 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26524953" @default.
- W2185409974 hasPublicationYear "2015" @default.
- W2185409974 type Work @default.
- W2185409974 sameAs 2185409974 @default.
- W2185409974 citedByCount "119" @default.
- W2185409974 countsByYear W21854099742016 @default.
- W2185409974 countsByYear W21854099742017 @default.
- W2185409974 countsByYear W21854099742018 @default.
- W2185409974 countsByYear W21854099742019 @default.
- W2185409974 countsByYear W21854099742020 @default.
- W2185409974 countsByYear W21854099742021 @default.
- W2185409974 countsByYear W21854099742022 @default.
- W2185409974 countsByYear W21854099742023 @default.
- W2185409974 crossrefType "journal-article" @default.
- W2185409974 hasAuthorship W2185409974A5008765259 @default.
- W2185409974 hasAuthorship W2185409974A5023460508 @default.
- W2185409974 hasAuthorship W2185409974A5029780470 @default.
- W2185409974 hasAuthorship W2185409974A5034906860 @default.
- W2185409974 hasAuthorship W2185409974A5050193171 @default.
- W2185409974 hasAuthorship W2185409974A5055567713 @default.
- W2185409974 hasAuthorship W2185409974A5070264785 @default.
- W2185409974 hasAuthorship W2185409974A5081445104 @default.
- W2185409974 hasAuthorship W2185409974A5085025467 @default.
- W2185409974 hasAuthorship W2185409974A5087378677 @default.
- W2185409974 hasBestOaLocation W21854099741 @default.
- W2185409974 hasConcept C121608353 @default.
- W2185409974 hasConcept C126322002 @default.
- W2185409974 hasConcept C142724271 @default.
- W2185409974 hasConcept C178596483 @default.
- W2185409974 hasConcept C203014093 @default.
- W2185409974 hasConcept C204232928 @default.
- W2185409974 hasConcept C2776256026 @default.